Safety and Effectiveness of Indomethacin versus Ibuprofen for Treatment of Patent Ductus Arteriosus
- 11 December 2009
- journal article
- research article
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 27 (05), 425-429
- https://doi.org/10.1055/s-0029-1243371
Abstract
We compared the rates of medical closure of patent ductus arteriosus (PDA) and complications (renal dysfunction, necrotizing enterocolitis, spontaneous intestinal perforation, and intraventricular hemorrhage) between infants treated with indomethacin and infants treated with ibuprofen. We performed a retrospective comparative cohort study of infants treated with indomethacin or ibuprofen for symptomatic PDA at Duke University Medical Center between November 2005 and November 2007. We identified 65 infants who received indomethacin and 57 who received ibuprofen. The rate of survival without surgical ductal ligation was 62% (40/65) in the indomethacin group and 58% (33/57) in the ibuprofen group (p = 0.71). The rate of the composite of complications (death, necrotizing enterocolitis, or intestinal perforation) was 40% (26/65) in the indomethacin group and 32% (18/57) in the ibuprofen group (p = 0.35). There was no significant difference between groups in elevation of serum creatinine during treatment. In clinical practice, ibuprofen appears to be as effective as indomethacin for closure of patent ductus arteriosus with similar complication rates. The decision to use one agent over the other should be based on dose schedule preference and the currently published clinical trials until more safety and effectiveness data are available.Keywords
This publication has 14 references indexed in Scilit:
- A Randomized, Double-Blind, Placebo-Controlled Trial on Intravenous Ibuprofen L-Lysine for the Early Closure of Nonsymptomatic Patent Ductus Arteriosus within 72 Hours of Birth in Extremely Low-Birth-Weight InfantsAmerican Journal of Perinatology, 2008
- Treatment of patent ductus arteriosus: indomethacin or ibuprofen?Journal of Perinatology, 2008
- Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trialArchives of Disease in Childhood: Fetal & Neonatal, 2007
- Drug Pricing in Pediatrics: The Egregious Example of IndomethacinPublished by American Academy of Pediatrics (AAP) ,2007
- Renal effects of ibuprofen for the treatment of patent ductus arteriosus in premature infantsThe Journal of Maternal-Fetal & Neonatal Medicine, 2007
- Ibuprofen Lysine (Neoprofen) for the Treatment of Patent Ductus ArteriosusBaylor University Medical Center Proceedings, 2007
- Systematic Review: Intravenous Ibuprofen in Preterm NewbornsSeminars in Perinatology, 2006
- Ibuprofeno frente a indometacina en el tratamiento del conducto arterioso persistente del prematuroAnales de Pediatría, 2005
- Prophylaxis of Early Adrenal Insufficiency to Prevent Bronchopulmonary Dysplasia: A Multicenter TrialPediatrics, 2004
- A Comparison of Ibuprofen and Indomethacin for Closure of Patent Ductus ArteriosusNew England Journal of Medicine, 2000